Utility of Free IGF-I Measurements
Author:
- 11 April 2007
- journal article
- review article
- Published by Springer Nature in Pituitary
- Vol. 10 (2) , 181-187
Abstract
For nearly 30 years, the endogenous bioactivity of insulin-like growth factor I (IGF-I) has been estimated by its circulating concentrations of immunoreactive IGF-I, obtained after either removal or inactivation of the IGF-binding proteins (IGFBPs), and today serum/plasma total IGF-I serves as a useful parameter in the diagnosis and clinical control of growth hormone (GH) disorders. Different assays for the measurement of free, unbound IGF-I were introduced more than a decade ago. Nevertheless, this measurement remains controversial, and in daily clinical practice serum total IGF-I has retained its position as the most widely used IGF-related measurement in GH disorders. This review will provide a survey of data on free versus total IGF-I, with particular reference to GH disorders. As it will be clear, there is reasonable clinical evidence to conclude that both in the diagnosis of as well as during treatment of patients with GH disorders, serum/plasma total IGF-I should remain the primary IGF-related measurement. However, in certain patients the inclusion of free IGF-I may be useful and therefore, some guidelines for the inclusion of free IGF-I measurements will be given.Keywords
This publication has 69 references indexed in Scilit:
- The somatostatin analogue SOM230, compared with octreotide, induces differential effects in several metabolic pathways in acromegalic patientsClinical Endocrinology, 2005
- Insulin-like growth factors and neoplasiaNature Reviews Cancer, 2004
- Usefulness of Different Biochemical Markers of the Insulin-Like Growth Factor (IGF) Family in Diagnosing Growth Hormone Excess and Deficiency in AdultsThe Journal of Clinical Endocrinology & Metabolism, 2001
- Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophyKidney International, 2000
- Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failureKidney International, 1999
- Recovery of Growth Hormone Release from Suppression by Exogenous Insulin-Like Growth Factor I (IGF-I): Evidence for a Suppressive Action of Free Rather Than Bound IGF-IThe Journal of Clinical Endocrinology & Metabolism, 1998
- The Diagnosis of Growth Hormone Deficiency in Children and AdultsEndocrine Reviews, 1998
- Measurement of Free Insulin-Like Growth Factor-I Using Immunoradiometric AssayJournal of Immunoassay, 1994
- Diagnosis of growth-hormone deficiency in adultsThe Lancet, 1994
- Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short childrenThe Journal of Clinical Endocrinology & Metabolism, 1993